SCHEMBL1994137

SCHEMBL1994137

Cc1cccc2c(CC(N)=O)nc(N3CCN(C)CC3)nc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 9/20 0.50
PRKCA P17252 1/20 0.46
PRKCH P24723 1/20 0.46
PRKCE Q02156 1/20 0.46
PRKCQ Q04759 1/20 0.46
PRKCD Q05655 1/20 0.46
HTR3A P46098 1/20 0.42
HTR6 P50406 4/20 0.41
KDM4E B2RXH2 2/20 0.41
HTT P42858 2/20 0.41
GLA P06280 1/20 0.41
BLM P54132 1/20 0.41
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
HTR2A P28223 2/20 0.39
HTR1A P08908 1/20 0.39
DRD2 P14416 1/20 0.39
HTR7 P34969 1/20 0.39
HTR2C P28335 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1996197 0.85 HRH4 (0.45) HRH4PRKCAPRKCHPRKCEPRKCQ
SCHEMBL1993681 0.82 HRH4 (0.61) HRH4HTR3AKDM4EHTTGLA
SCHEMBL1994195 0.81 HRH4 (0.57) HRH4PRKCAPRKCHPRKCEPRKCQ
SCHEMBL1993409 0.77 HRH4 (0.50) HRH4PRKCAPRKCHPRKCEPRKCQ
SCHEMBL1992580 0.76 GGPS1 (0.42) HRH4HTR3AHTR6KDM4EHTT
SCHEMBL1995226 0.74 LATS1 (0.45) HRH4HTR3AHTR6KDM4EHTT
SCHEMBL2001802 0.74 HRH4 (0.50) HRH4HTR3AHTR6KDM4EHTT
SCHEMBL1990158 0.74 HRH4 (0.49) HRH4PRKCAPRKCHPRKCEPRKCQ
SCHEMBL1993947 0.74 PRKCB (0.45) HRH4PRKCAPRKCHPRKCEPRKCQ
SCHEMBL1991112 0.74 HRH4 (0.65) HRH4HTR3AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO HRH4 249/4885PRKCA 3438/4885PRKCH 3138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.